clinical trial · NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Merck Sharp & Dohme LLC·phase1·recruiting·n = 21
Systemic Lupus ErythematosusRheumatoid ArthritisMK-1045
brief summary
This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).
started
Feb 19, 2026
primary completion
Jul 16, 2029
completion
Jul 16, 2029
last updated
May 4, 2026
official title
A Dose Escalation Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1045 in Participants With Systemic Lupus Erythematosus and Rheumatoid Arthritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol